机译:光动力治疗产生的人乳腺癌细胞MCF-7及其多药耐药细胞的细胞损伤比较
Shaanxi Normal Univ, Key Lab, Minist Educ Med Plant Resources & Nat Pharmaceut, Coll Life Sci, Xian, Shaanxi, Peoples R China;
Shaanxi Normal Univ, Key Lab, Minist Educ Med Plant Resources & Nat Pharmaceut, Coll Life Sci, Xian, Shaanxi, Peoples R China;
Shaanxi Normal Univ, Key Lab, Minist Educ Med Plant Resources & Nat Pharmaceut, Coll Life Sci, Xian, Shaanxi, Peoples R China;
Shaanxi Normal Univ, Key Lab, Minist Educ Med Plant Resources & Nat Pharmaceut, Coll Life Sci, Xian, Shaanxi, Peoples R China;
Shaanxi Normal Univ, Key Lab, Minist Educ Med Plant Resources & Nat Pharmaceut, Coll Life Sci, Xian, Shaanxi, Peoples R China;
Shaanxi Normal Univ, Key Lab, Minist Educ Med Plant Resources & Nat Pharmaceut, Coll Life Sci, Xian, Shaanxi, Peoples R China;
Adriamycin resistant cell; MCF-7; Ce6-PDT; Apoptosis; Autophagy;
机译:人类乳腺癌细胞特性的比较:选择对依托泊苷具有抗性的MCF-7和MCF-7细胞。
机译:治疗性超声波对人乳腺癌MCF-7和MCF-7 / ADR细胞的细胞膜损伤的比较
机译:MCF-7 / ADR细胞(重新指定为NCI / ADR-RES)并非源自MCF-7乳腺癌细胞:对乳腺癌多药耐药性研究的损失。
机译:MPEG-PCL-移植纤维素的胶束药物载体克服乳腺癌细胞的多药耐药性
机译:Photofrin介导的MCF-7人乳腺癌和B16-F10小鼠黑素瘤细胞的电穿孔辅助光动力疗法。
机译:ATG7缺乏增加MCF-7人乳腺癌细胞对光动力治疗的抗性
机译:从正常到高葡萄糖水平的偏移刺激药物敏感MCF-7人乳腺癌细胞中的细胞增殖,但不在多药抗性MCF-7 / ADR细胞中,其过度提出PKC-?II